Cargando…
Anti‐tumor Effects of Interleukin‐4 and Interleukin‐5 against Mouse B Cell Lymphoma and Possible Mechanisms of Their Action
We investigated the anti‐tumor effects of recombinant mouse interleukin (IL)‐4 and IL‐5 by using a transplantable B cell lymphoma 38C13 cell line as a model. Daily local administration of either IL‐4 or IL‐5 produced moderate but significant inhibition of the rate of local tumor growth and prolongat...
Autores principales: | Wu, Hua‐Lang, Hirai, Hisamaru, Inamori, Ken, Kitamura, Kiyoshi, Takaku, Fumimaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918788/ https://www.ncbi.nlm.nih.gov/pubmed/1556001 http://dx.doi.org/10.1111/j.1349-7006.1992.tb00087.x |
Ejemplares similares
-
Mutations of N‐ras Oncogene in Myelodysplastic Syndromes and Lcukemias Detected by Polymerase Chain Reaction
por: Mano, Hiroyuki, et al.
Publicado: (1989) -
Interleukin-6 and Interleukin-15 as Possible Biomarkers of the Risk of Autoimmune Diabetes Development
por: Siewko, Katarzyna, et al.
Publicado: (2019) -
Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2 diabetes
por: Barry, Julianne C., et al.
Publicado: (2016) -
Anti‐interleukin‐17A and anti‐interleukin‐23 antibodies may be effective against Alzheimer's disease: Role of neutrophils in the pathogenesis
por: Katayama, Hiroshi
Publicado: (2019) -
Interleukin-24 protects against liver injury in mouse models
por: Wang, Hsiao-Hsuan, et al.
Publicado: (2021)